Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Jasmanda Wu
Comparable Glycaemic Control and Hypoglycaemia in Adults With Type 2 Diabetes After Initiating Insulin Glargine 300 Units/mL or Insulin Degludec: DELIVER Naïve D Real‐world Study
Diabetes, Obesity and Metabolism
Internal Medicine
Endocrinology
Metabolism
Diabetes
Related publications
Glycaemic Control, Hypoglycaemia, and Weight Change With Insulin Glargine 300 U/mL Versus Insulin Glargine 100 U/mL in Japanese Adults With Type 2 Diabetes: A 12-Month Comparison by Concomitant Sulphonylurea and/or Glinide Use
Diabetes, Obesity and Metabolism
Internal Medicine
Endocrinology
Metabolism
Diabetes
Pdb86 - Cost-Utility Analysis of Insulin Glargine 300 U/Ml Versus Insulin Glargine 100 U/Ml and Insulin Degludec 100 U/Ml in Patients With Type 2 Diabetes Mellitus in Bulgaria
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Pdb79 - Cost-Utility Analysis of Insulin Glargine 300 U/Ml Versus Insulin Glargine 100 U/Ml and Insulin Degludec 100 U/Ml in Patients With Type 2 Diabetes Mellitus in Croatia
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
In Silico Head-To-Head Comparison of Insulin Glargine 300 U/Ml and Insulin Degludec 100 U/Ml in Type 1 Diabetes
Diabetes Technology and Therapeutics
Medicine
Endocrinology
Medical Laboratory Technology
Metabolism
Diabetes
Achieve Control: A Pragmatic Clinical Trial of Insulin Glargine 300 U/mL Versus Other Basal Insulins in Insulin-Naïve Patients With Type 2 Diabetes
Postgraduate Medicine
Medicine
Cost-Effectiveness of Insulin Degludec Compared With Insulin Glargine for Patients With Type 2 Diabetes Mellitus Initiating Insulin Therapy in the United Kingdom
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Real-World Outcomes of Treatment With Insulin Glargine 300 u/mL Versus Standard-Of-Care in People With Uncontrolled Type 2 Diabetes Mellitus
Current Medical Research and Opinion
Medicine
Efficacy and Safety of Insulin Glargine 300 U/mL Versus Insulin Degludec in Patients With Type 2 Diabetes: A Randomized, Open-Label, Crossover Study Using Continuous Glucose Monitoring Profiles
Journal of Diabetes Investigation
Internal Medicine
Endocrinology
Metabolism
Medicine
Diabetes
Switching From Neutral Protamine Hagedorn Insulin to Insulin Glargine 300 U/mL Improves Glycaemic Control and Reduces Hypoglycaemia Risk: Results of a Multicentre, Prospective, Observational Study
Journal of Diabetes Research
Endocrinology
Metabolism
Diabetes
